The spectrum and treatment of virus-associated vasculitides

Current Opinion in Rheumatology

Volumn 9, Issue 1, 1997, Pages 31-36

  Guillevin, Loïc ^a   Lhote, François ^a   Ghérardi, Romain ^b  

^a UNIVERSITÉ PARIS 13   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CYTOTOXIC AGENT; IMMUNOMODULATING AGENT; STEROID; VASODILATOR AGENT; VIRUS ANTIBODY;

ANTIGEN ANTIBODY COMPLEX; CRYOGLOBULINEMIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; ISCHEMIA; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; SEROCONVERSION; SHORT SURVEY; SYSTEMIC VASCULITIS; VASCULITIS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0030962739     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199701000-00006     Document Type: Short Survey

References (20)

1. Trépo C, Thivolet J: Antigène Australia: hépatite à virus et périartérite noueuse [letter]. Presse Med 1970, 78:1575.
2. Ferri C, Greco F, Longombardo G, et al.: Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991, 9:621-624.
3. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992, 327:1490-1495.
4. Guillevin L, Lhote F, Léon A, Fauvelle F, Vivitski L, Trépo C: Treatment of polyarteritis nodosa related to hepatitis B virus with short-term steroid therapy associated with antiviral agents and plasma exchanges: a prospective trial in 33 patients. J Rheumatol 1993, 20:289-298.
5. Guillevin L, Lhote F, Cohen P, et al.: Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995, 74:238-253. This prospective study describes the characteristics and outcome of HBV-related polyarteritis nodosa. Antiviral treatment and plasma exchanges were able to cure 83% of patients and to achieve HBe-to-anti-HBe seroconversion in 51.2% of cases.
6. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME: Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993, 20:304-309.
7. Quint L, Dény P, Guillevin L, et al.: Hepatitis C virus in patients with polyarteritis nodosa, prevalence in 38 patients. Clin Exp Rheumatol 1991, 9:253-257.
8. Calabrese LH: Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am 1991, 17:131-147.
9. Cohen P, Guillevin L, Gayraud M, et al.: Successful treatment of HIV-related vasculitis with peripheral neuropathy by the association of zidovudine and plasmapheresis. Transfusion Sci 1993, 14:383-389.
10. Ghérardi R, Belec L, Mhiri C, et al.: The spectrum of vasculitis in human immunodeficiency virus-infected patients: clinicopathologic evaluation. Arthritis Rheum 1993, 36:1164-1174.
11. Finkel TH, Torok TJ, Ferguson PJ, et al.: Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994, 343:1255-1258.
12. Leruez VM, Lauge A, Morinet F, Guillevin L, Dény P: Polyarteritis nodosa and parvovirus B19. Lancet 1994, 344:263-264.
13. Golden MP, Hammer SM, Wanke CA, Albrecht MA: Cytomegalovirus vasculitis: case reports and review of the literature. Medicine (Baltimore) 1994, 73:246-255.
14. Somer T, Finegold S: Vasculitides associated with infections, immunization and antimicrobial drugs. Clin Infect Dis 1995, 20:1010-1036. This excellent review focuses on the viral causes, classification, clinical characteristics, and treatment of infectious vasculitides.
15. Simsek H, Telatar H: Successful treatment of hepatitis B virus-associated polyarteritis nodosa by interferon alpha alone. J Clin Gastroenterol 1995, 20:263-265. This short paper describes the favorable outcome of a patient treated with interferon alpha for HBV-related polyarteritis nodosa.
16. Guillevin L, Lhote F, Sauvaget F, et al.: Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 1994, 53:334-337.
17. Ferri C, Marzo E, Longombardo G, et al.: Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993, 81:1132-1136.
18. Cohen P, Tri Nguyen Q, Ferriére F, et al.: Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. Ann Med Interne (Paris) 1996, 147:81-86. This prospective study describes results obtained in patients with systemic cryoglobulinemia who received interferon alpha plasma exchanges or steroids. Improvement was observed in the majority of patients but 91.6% of them suffered relapses.
19. Misiani R, Bellavita P, Fenili D, et al.: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994, 330:751-756.
20. Gisselbrecht M, Cohen P, Lortholary O, et al.: HIV-related vasculitis: clinical presentation and therapeutic approach on six patients. AIDS 1997, 11:121-123.